Werewolf Therapeutics Inc (HOWL)

Werewolf Therapeutics Inc (HOWL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $45.2M; returns 1 day -3.0%, 1 week +0.0%, 1 year -37.6%.

Werewolf Therapeutics Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary PREDATOR platform to engineer 'indukines'—conditionally activated cytokines designed to stimulate the immune system specifically within the tumor microenvironment while remaining inactive in systemic circulation.

Groups HOWL belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Oncology
• Immunotherapy
• Biopharmaceutical
• Cancer Therapeutics
• Strategic Partnerships
• Precision Medicine

HOWL financial model: income statement, cash flow and balance sheet